Biotechnology company Ophthotech raises $125m from Nova A/s and $50m in a series C to bring the company's total funding to $205m.

UniQuest, the commercialisation unit of the University of Queensland, appoints Dr Dean Moss as chief executive.

Edinburgh Research and Innovation is seeking partners to commercialise the next generation of malaria drugs and vaccine.

AstraZeneca reveals plans to use $500m to establish a global R&D centre and its corporate headquarters in Cambridge.

Frankfurt-listed drug discovery business Evotec will harness the power of its comprehensive drug discovery infrastructure and expertise, using assays, chemical starting points and x-ray crystallographic tools licensed from Harvard.

Morgan Stanley-backed EKOS snapped up for $180m.

Biogen Idec-backed Portola Pharmaceuticals raises $122m on Nasdaq.